Recent News

New approach to ovarian cancer treatment uses RNA-based nanodrugs

In a study conducted at Tel Aviv University (TAU), the protein CKAP5 (cytoskeleton-associated protein) was used for the first time as a therapeutic target for RNA-based nanodrugs.  After identifying a genetically unstable mutation resistant to both chemotherapy and immunotherapy in the tissues of ovarian cancer, the researchers targeted these cells with lipid nanoparticles containing RNA… Read More

TAU professors influence Israel and the world, top Israeli media say

On the eve of Israel’s 75th birthday, two leading researchers at Tel Aviv University (TAU) have been recognized for their contributions to Israel and the world. The financial newspaper Globes named Professor Karen Avraham, the first female Dean of TAU’s Faculty of Medicine, one of the 50 Most Influential Women in Israel. Professor Avraham is… Read More

New TAU study finds that pregnancy affects sensing capabilities of bats

A new Tel Aviv University (TAU) study reveals that bats experience a decline in their ability to hunt and orient in space during pregnancy. This impairment stems from the fact that they produce about 20 percent fewer calls, the sounds that allow them to orient themselves using echolocation, on top of flying at a slower… Read More